Net Cash Provided by (Used in) Operating Activities |
5.93M |
USD |
|
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
625K |
USD |
|
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
200M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
91.8M |
shares |
+2.85% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
11.2M |
USD |
+29.2% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Valuation Allowance |
0 |
USD |
-100% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
21.6M |
USD |
-34.8% |
Q4 2024 |
FY 2024 |
Operating Lease, Liability |
299K |
USD |
+9.52% |
Q2 2025 |
Q2 2025 |
Lessee, Operating Lease, Liability, to be Paid |
318K |
USD |
+5.3% |
Q2 2025 |
Q2 2025 |
Operating Lease, Liability, Current |
174K |
USD |
+85.1% |
Q2 2025 |
Q2 2025 |
Lessee, Operating Lease, Liability, to be Paid, Year Two |
191K |
USD |
+66.1% |
Q2 2025 |
Q2 2025 |
Lessee, Operating Lease, Liability, to be Paid, Year One |
95K |
USD |
-15.2% |
Q2 2025 |
Q2 2025 |
Operating Lease, Weighted Average Discount Rate, Percent |
0.08 |
pure |
0% |
Q2 2025 |
Q2 2025 |
Deferred Income Tax Expense (Benefit) |
76K |
USD |
|
Q1 2025 |
Q1 2025 |
Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
19K |
USD |
-34.5% |
Q2 2025 |
Q2 2025 |
Lessee, Operating Lease, Liability, to be Paid, Year Three |
19K |
USD |
|
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
19.5M |
USD |
-37.5% |
Q4 2024 |
FY 2024 |
Current Income Tax Expense (Benefit) |
76K |
USD |
|
Q1 2025 |
Q1 2025 |
Additional Paid in Capital |
228M |
USD |
+0.89% |
Q2 2025 |
Q2 2025 |
Depreciation, Depletion and Amortization |
2.58M |
USD |
+36.9% |
Q1 2023 |
Q1 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Share-based Payment Arrangement, Expense |
412K |
USD |
|
Q1 2023 |
Q1 2023 |